Cargando…

Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial

Equus asinus L [Equidae; Asini Corii Colla] (donkey-hide gelatin, Ejiao), a well-known traditional Chinese medicine, has been widely used to nourish the blood, especially for women. The aim of this study was to assess the efficacy and safety of Ejiao in blood-deficient patients. A total of 210 parti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li, Xu, Zhongju, Jiang, Tao, Zhang, Jialu, Huang, Pinxian, Tan, Jiaqi, Chen, Gan, Yuan, Man, Li, Zhuo, Liu, Haibin, Gao, Dengfeng, Xiao, Lianbo, Feng, Hui, Xu, Jiatuo, Xu, Hongxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542698/
https://www.ncbi.nlm.nih.gov/pubmed/34707496
http://dx.doi.org/10.3389/fphar.2021.718154
_version_ 1784589474599010304
author Zhang, Li
Xu, Zhongju
Jiang, Tao
Zhang, Jialu
Huang, Pinxian
Tan, Jiaqi
Chen, Gan
Yuan, Man
Li, Zhuo
Liu, Haibin
Gao, Dengfeng
Xiao, Lianbo
Feng, Hui
Xu, Jiatuo
Xu, Hongxi
author_facet Zhang, Li
Xu, Zhongju
Jiang, Tao
Zhang, Jialu
Huang, Pinxian
Tan, Jiaqi
Chen, Gan
Yuan, Man
Li, Zhuo
Liu, Haibin
Gao, Dengfeng
Xiao, Lianbo
Feng, Hui
Xu, Jiatuo
Xu, Hongxi
author_sort Zhang, Li
collection PubMed
description Equus asinus L [Equidae; Asini Corii Colla] (donkey-hide gelatin, Ejiao), a well-known traditional Chinese medicine, has been widely used to nourish the blood, especially for women. The aim of this study was to assess the efficacy and safety of Ejiao in blood-deficient patients. A total of 210 participants were recruited and randomly allocated into the placebo control group and Ejiao-treated group (6 g/day). The primary outcomes on the efficacy of Ejiao included traditional Chinese medicine symptom scores, blood indicators, and SF-36. The secondary outcomes were changes in fireness and safety evaluation. Results showed that Ejiao treatment for 8 weeks had significantly improved dizziness symptoms. Among the tested 24 blood biochemical parameters, the hematocrit and red blood cell numbers decreased in the placebo control group, but decreased significantly less in the Ejiao treatment group. The white blood cell and neutrophil counts increased in the Ejiao group but were within the normal range. In addition, the quality of life improved as the scores in SF-36 domains were significantly higher in the Ejiao group. At the same time, there was no significant change in the fire–heat symptoms score or other safety parameters. Considering all these, our study showed that Ejiao has a promising effect in women suffering from blood deficiency without obvious adverse effects.
format Online
Article
Text
id pubmed-8542698
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85426982021-10-26 Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial Zhang, Li Xu, Zhongju Jiang, Tao Zhang, Jialu Huang, Pinxian Tan, Jiaqi Chen, Gan Yuan, Man Li, Zhuo Liu, Haibin Gao, Dengfeng Xiao, Lianbo Feng, Hui Xu, Jiatuo Xu, Hongxi Front Pharmacol Pharmacology Equus asinus L [Equidae; Asini Corii Colla] (donkey-hide gelatin, Ejiao), a well-known traditional Chinese medicine, has been widely used to nourish the blood, especially for women. The aim of this study was to assess the efficacy and safety of Ejiao in blood-deficient patients. A total of 210 participants were recruited and randomly allocated into the placebo control group and Ejiao-treated group (6 g/day). The primary outcomes on the efficacy of Ejiao included traditional Chinese medicine symptom scores, blood indicators, and SF-36. The secondary outcomes were changes in fireness and safety evaluation. Results showed that Ejiao treatment for 8 weeks had significantly improved dizziness symptoms. Among the tested 24 blood biochemical parameters, the hematocrit and red blood cell numbers decreased in the placebo control group, but decreased significantly less in the Ejiao treatment group. The white blood cell and neutrophil counts increased in the Ejiao group but were within the normal range. In addition, the quality of life improved as the scores in SF-36 domains were significantly higher in the Ejiao group. At the same time, there was no significant change in the fire–heat symptoms score or other safety parameters. Considering all these, our study showed that Ejiao has a promising effect in women suffering from blood deficiency without obvious adverse effects. Frontiers Media S.A. 2021-10-11 /pmc/articles/PMC8542698/ /pubmed/34707496 http://dx.doi.org/10.3389/fphar.2021.718154 Text en Copyright © 2021 Zhang, Xu, Jiang, Zhang, Huang, Tan, Chen, Yuan, Li, Liu, Gao, Xiao, Feng, Xu and Xu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhang, Li
Xu, Zhongju
Jiang, Tao
Zhang, Jialu
Huang, Pinxian
Tan, Jiaqi
Chen, Gan
Yuan, Man
Li, Zhuo
Liu, Haibin
Gao, Dengfeng
Xiao, Lianbo
Feng, Hui
Xu, Jiatuo
Xu, Hongxi
Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
title Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
title_full Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
title_fullStr Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
title_full_unstemmed Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
title_short Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
title_sort efficacy and safety of ejiao (asini corii colla) in women with blood deficient symptoms: a randomized, double-blind, and placebo-controlled clinical trial
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542698/
https://www.ncbi.nlm.nih.gov/pubmed/34707496
http://dx.doi.org/10.3389/fphar.2021.718154
work_keys_str_mv AT zhangli efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT xuzhongju efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT jiangtao efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT zhangjialu efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT huangpinxian efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT tanjiaqi efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT chengan efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT yuanman efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT lizhuo efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT liuhaibin efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT gaodengfeng efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT xiaolianbo efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT fenghui efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT xujiatuo efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT xuhongxi efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial